Help4ME is one of the few ME/CFS research projects the European Union has invested in. It will test the efficacy of GutMagnific®, a probiotic designed to correct the gut microflora imbalance in patients with ME/CFS. The project is coordinated by ImmuneBiotech Medical Sweden AB and has received an EU contribution of 50.000 euro through the Horizon 2020 research program.
Further reading
- Learn more about Help4ME and its grant agreement on the website of the European Commission.
- EMEC’s response to research projects funded by the European Commission can be found here.